RAR β 2 Antibodies

Santa Cruz Biotechnology offers a broad range of RAR β2 monoclonal antibodies for research focused on understanding retinoic acid receptors. RAR β2 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RAR β2, a member of the nuclear receptor superfamily, plays a crucial role in mediating the effects of retinoic acid on gene expression, influencing processes such as cell differentiation, proliferation, and apoptosis. Understanding RAR β2 function has significant implications for developmental biology and cancer research, making it an important target for therapeutic interventions and biomarker studies. RAR β2 is essential for maintaining cellular homeostasis and regulating gene transcription in response to retinoic acid signals. Researchers have identified RAR β2 as a potential tumor suppressor, with its expression often altered in various cancer types. Current studies are exploring how RAR β2 signaling pathways contribute to both normal development and disease progression. The high-quality monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of retinoic acid receptor biology and its impact on human health.